Get the Stockscreener App
20.23
0.98%
-0.20
After Hours:
19.51
-0.72
-3.56%
Ishares Genomics Immunology And Healthcare Etf stock is traded at $20.23, with a volume of 48,301.
It is down -0.98% in the last 24 hours and down -3.76% over the past month.
See More
Previous Close:
$20.43
Open:
$20.19
24h Volume:
48,301
Relative Volume:
1.42
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.75%
1M Performance:
-3.76%
6M Performance:
-18.16%
1Y Performance:
-14.64%
1-Day Range:
$19.86
$20.23
1-Week Range:
$19.86
$20.43
52-Week Range:
$17.26
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Name
Ishares Genomics Immunology And Healthcare Etf
Sector
Industry
Phone
-
Address
-
Compare IDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
20.23 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
289.88 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
589.39 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
592.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
228.19 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
519.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Latest News
Objective long/short (XDNA) Report (XDNA:CA) - news.stocktradersdaily.com
(XDNA) Trading Advice (XDNA:CA) - news.stocktradersdaily.com
Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal - Benzinga
(XDNA) Stock Trading Blueprint (XDNA:CA) - news.stocktradersdaily.com
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - Zacks Investment Research
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for March 2025 - Wealth Awesome
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - Money/ US News
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
3 Themes Growth and Tech Investors May Want to Consider in 2023 - Nasdaq
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
3 genome ETFs to watch in 2021 - CMC Markets
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
3 ETFs For More Moderna Bets - Yahoo
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Financials Data
There is no financial data for Ishares Genomics Immunology And Healthcare Etf (IDNA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.16%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):